688617 Stock Overview
APT Medical Inc. engages in the research, development, production, and sale of electrophysiology and interventional medical devices in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 6/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 688617 from our risk checks.
APT Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥466.09 |
| 52 Week High | CN¥479.96 |
| 52 Week Low | CN¥293.60 |
| Beta | -0.51 |
| 1 Month Change | 7.80% |
| 3 Month Change | 29.73% |
| 1 Year Change | 38.54% |
| 3 Year Change | 76.54% |
| 5 Year Change | n/a |
| Change since IPO | 81.34% |
Recent News & Updates
APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively
Apr 10
Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today
Mar 19Shareholder Returns
| 688617 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 1.3% | -1.6% | -0.4% |
| 1Y | 38.5% | -21.5% | -16.2% |
Return vs Industry: 688617 exceeded the CN Medical Equipment industry which returned -21.5% over the past year.
Return vs Market: 688617 exceeded the CN Market which returned -16.2% over the past year.
Price Volatility
| 688617 volatility | |
|---|---|
| 688617 Average Weekly Movement | 5.4% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 688617's share price has been volatile over the past 3 months.
Volatility Over Time: 688617's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 2,155 | Zhenghui Cheng | www.aptmed.com |
APT Medical Inc. engages in the research, development, production, and sale of electrophysiology and interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, and transseptal needle and sheaths; and interventional cardiology and peripheral intervention products, such as access, diagnostic products, and therapeutic products. It also provides catheters, guidewires, delivery systems, and nitinol products in cardiology, peripheral, neurology, urology, etc. therapeutic applications, as well as accessories; and OEM/ODM services, including project design and development, customization, and volume OEM, etc. The company also exports its products to the United States, Japan, the European Union, Latin America, the Middle East, Russia, the Commonwealth of Independent States, and Africa.
APT Medical Inc. Fundamentals Summary
| 688617 fundamental statistics | |
|---|---|
| Market cap | CN¥31.10b |
| Earnings (TTM) | CN¥533.92m |
| Revenue (TTM) | CN¥1.65b |
58.1x
P/E Ratio18.8x
P/S RatioIs 688617 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688617 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.65b |
| Cost of Revenue | CN¥486.14m |
| Gross Profit | CN¥1.16b |
| Other Expenses | CN¥630.15m |
| Earnings | CN¥533.92m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 8.02 |
| Gross Margin | 70.54% |
| Net Profit Margin | 32.35% |
| Debt/Equity Ratio | 3.7% |
How did 688617 perform over the long term?
See historical performance and comparison